These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
486 related items for PubMed ID: 17403613
1. N-terminal pro brain natriuretic peptide to predict prognosis in dilated cardiomyopathy with sinus rhythm. Tigen K, Karaahmet T, Kahveci G, Tanalp AC, Bitigen A, Fotbolcu H, Bayrak F, Mutlu B, Basaran Y. Heart Lung Circ; 2007 Aug; 16(4):290-4. PubMed ID: 17403613 [Abstract] [Full Text] [Related]
7. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy. Dini FL, Fontanive P, Conti U, Andreini D, Cabani E, De Tommasi SM. Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528 [Abstract] [Full Text] [Related]
8. Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy. D'Amato R, Tomberli B, Castelli G, Spoladore R, Girolami F, Fornaro A, Caldini A, Torricelli F, Camici P, Gensini GF, Cecchi F, Olivotto I. Am J Cardiol; 2013 Oct 15; 112(8):1190-6. PubMed ID: 23871673 [Abstract] [Full Text] [Related]
9. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure. Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E. Cardiol J; 2009 Oct 15; 16(1):43-9. PubMed ID: 19130415 [Abstract] [Full Text] [Related]
10. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle. Barbosa MM, Nunes Mdo C, Ribeiro AL, Barral MM, Rocha MO. Eur J Echocardiogr; 2007 Jun 15; 8(3):204-12. PubMed ID: 16651029 [Abstract] [Full Text] [Related]
12. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure. Dini FL, Gabutti A, Passino C, Fontanive P, Emdin M, De Tommasi SM. Int J Cardiol; 2010 Apr 30; 140(3):344-50. PubMed ID: 19128846 [Abstract] [Full Text] [Related]
13. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooley MA. JAMA; 2007 Jan 10; 297(2):169-76. PubMed ID: 17213400 [Abstract] [Full Text] [Related]
14. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E. Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998 [Abstract] [Full Text] [Related]
18. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. Rothenburger M, Wichter T, Schmid C, Stypmann J, Tjan TD, Berendes E, Etz C, Pioux A, Löher A, Wenzelburger F, Drees G, Hoffmeier A, Breithardt G, Scheld HH. J Heart Lung Transplant; 2004 Oct 15; 23(10):1189-97. PubMed ID: 15477114 [Abstract] [Full Text] [Related]
19. Left ventricular cavity area reflects N-terminal pro-brain natriuretic peptide plasma levels in heart failure. Taléns-Visconti R, Rivera Otero M, Sancho-Tello MJ, de Burgos FG, Martínez-Dolz L, Sevilla B, Climent V, Cortés R, Salvador A, Sogorb F, Miro V, Valero R, Perez-Boscá JL, Bertomeu V, Portolés M, Payá R. Eur J Echocardiogr; 2006 Jan 15; 7(1):45-52. PubMed ID: 15939671 [Abstract] [Full Text] [Related]